Onconetix, Inc. (ONCO)

Onconetix Statistics

Total Valuation

Onconetix has a market cap or net worth of $824,583. The enterprise value is -$4.28 million.

Market Cap	824,583
Enterprise Value	-4.28M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Onconetix has 692,927 shares outstanding.

Current Share Class	692,927
Shares Outstanding	692,927
Shares Change (YoY)	n/a
Shares Change (QoQ)	+11.60%
Owned by Insiders (%)	0.51%
Owned by Institutions (%)	1.86%
Float	632,019

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.10
Forward PS	n/a
PB Ratio	0.03
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.66, with a Debt / Equity ratio of 0.00.

Current Ratio	0.66
Quick Ratio	0.61
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.45

Financial Efficiency

Return on equity (ROE) is -115.46% and return on invested capital (ROIC) is -23.46%.

Return on Equity (ROE)	-115.46%
Return on Assets (ROA)	-14.93%
Return on Invested Capital (ROIC)	-23.46%
Return on Capital Employed (ROCE)	-40.18%
Weighted Average Cost of Capital (WACC)	85.91%
Revenue Per Employee	$407,686
Profits Per Employee	-$7.77M
Employee Count	2
Asset Turnover	0.03
Inventory Turnover	1.70

Taxes

In the past 12 months, Onconetix has paid $525 in taxes.

Income Tax	525
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -96.05% in the last 52 weeks. The beta is 3.63, so Onconetix's price volatility has been higher than the market average.

Beta (5Y)	3.63
52-Week Price Change	-96.05%
50-Day Moving Average	3.88
200-Day Moving Average	12.09
Relative Strength Index (RSI)	31.59
Average Volume (20 Days)	3,962,082

Short Selling Information

The latest short interest is 260,259, so 37.56% of the outstanding shares have been sold short.

Short Interest	260,259
Short Previous Month	37,915
Short % of Shares Out	37.56%
Short % of Float	41.18%
Short Ratio (days to cover)	0.56

Income Statement

In the last 12 months, Onconetix had revenue of $815,371 and -$15.53 million in losses. Loss per share was -$82.81.

Revenue	815,371
Gross Profit	632,913
Operating Income	-6.34M
Pretax Income	-14.03M
Net Income	-15.53M
EBITDA	-6.33M
EBIT	-6.34M
Loss Per Share	-$82.81

Balance Sheet

The company has $5.22 million in cash and $48,774 in debt, with a net cash position of $5.17 million or $7.46 per share.

Cash & Cash Equivalents	5.22M
Total Debt	48,774
Net Cash	5.17M
Net Cash Per Share	$7.46
Equity (Book Value)	15.76M
Book Value Per Share	50.53
Working Capital	-3.07M

Cash Flow

Operating Cash Flow	-9.68M
Capital Expenditures	n/a
Depreciation & Amortization	15,170
Net Borrowing	-5.78M
Free Cash Flow	-9.68M
FCF Per Share	-$13.97

Margins

Gross Margin	77.62%
Operating Margin	-778.16%
Pretax Margin	-1,720.91%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Onconetix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1,737.48%
FCF Yield	-1,082.74%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 25, 2026. It was a reverse split with a ratio of 1:5.

Last Split Date	Mar 25, 2026
Split Type	Reverse
Split Ratio	1:5

Scores

Onconetix has an Altman Z-Score of -8.09 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.09
Piotroski F-Score	3